CN101842486A - 生物膜的免疫治疗 - Google Patents

生物膜的免疫治疗 Download PDF

Info

Publication number
CN101842486A
CN101842486A CN200880104633A CN200880104633A CN101842486A CN 101842486 A CN101842486 A CN 101842486A CN 200880104633 A CN200880104633 A CN 200880104633A CN 200880104633 A CN200880104633 A CN 200880104633A CN 101842486 A CN101842486 A CN 101842486A
Authority
CN
China
Prior art keywords
polypeptide
gingivalis
composition
proteins
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880104633A
Other languages
English (en)
Chinese (zh)
Inventor
斯图尔特·杰弗里·达斯弗
埃里克·查尔斯·雷诺兹
保罗·大卫·维斯
洪振盛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oral Health Australia Pty Ltd
Original Assignee
Oral Health Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007903787A external-priority patent/AU2007903787A0/en
Application filed by Oral Health Australia Pty Ltd filed Critical Oral Health Australia Pty Ltd
Publication of CN101842486A publication Critical patent/CN101842486A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN200880104633A 2007-07-12 2008-07-11 生物膜的免疫治疗 Pending CN101842486A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2007903787A AU2007903787A0 (en) 2007-07-12 Immunology treatment for biofilms
AU2007903787 2007-07-12
PCT/AU2008/001018 WO2009006700A1 (en) 2007-07-12 2008-07-11 Immunology treatment for biofilms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN2012101357337A Division CN102652831A (zh) 2007-07-12 2008-07-11 生物膜的免疫治疗

Publications (1)

Publication Number Publication Date
CN101842486A true CN101842486A (zh) 2010-09-22

Family

ID=40228121

Family Applications (2)

Application Number Title Priority Date Filing Date
CN200880104633A Pending CN101842486A (zh) 2007-07-12 2008-07-11 生物膜的免疫治疗
CN2012101357337A Pending CN102652831A (zh) 2007-07-12 2008-07-11 生物膜的免疫治疗

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2012101357337A Pending CN102652831A (zh) 2007-07-12 2008-07-11 生物膜的免疫治疗

Country Status (10)

Country Link
US (2) US20100297179A1 (enExample)
EP (2) EP2604692A1 (enExample)
JP (2) JP2010532766A (enExample)
KR (1) KR20100071964A (enExample)
CN (2) CN101842486A (enExample)
AU (1) AU2008274907B2 (enExample)
CA (1) CA2693717A1 (enExample)
NZ (3) NZ582438A (enExample)
SG (1) SG182988A1 (enExample)
WO (1) WO2009006700A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105418758A (zh) * 2015-12-03 2016-03-23 沈阳惠民生物技术有限公司 一种抗牙周病抗体的制备方法及其应用
CN113005069A (zh) * 2021-01-28 2021-06-22 广东海洋大学 一种减毒鰤鱼诺卡氏菌及其制备方法和应用

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
US20100092471A1 (en) 2006-06-27 2010-04-15 Oral Health Australia Pty Ltd Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease
ES2714008T3 (es) 2007-07-12 2019-05-24 Oral Health Australia Pty Ltd Tratamiento de biopelícula
CN107266582B (zh) 2008-08-29 2021-09-10 口腔健康澳洲私人有限公司 牙龈卟啉单胞菌感染的预防、治疗和诊断
BR112012002429A2 (pt) * 2009-08-02 2016-11-08 Sanofi Pasteur Ltd polipeptídeos de porphyromonas gingivalis
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210035A (en) * 1980-05-19 1993-05-11 Board Of Trustees Of Leland Stanford Jr. University Non-reventing live vaccines
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US4837151A (en) 1980-05-19 1989-06-06 The Board Of Trustees Of The Leland Stanford Junior University, Stanford University Live vaccines comprising two mutations and foreign antigen
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US5830710A (en) 1988-09-08 1998-11-03 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
WO1994027606A1 (en) 1993-05-28 1994-12-08 Unisearch Limited Method of treating helicobacter pylori infection
US5711937A (en) * 1993-06-28 1998-01-27 Lion Corporation Oral composition
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
WO1995007286A1 (en) 1993-09-10 1995-03-16 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase coding sequences
US5475097A (en) * 1993-10-21 1995-12-12 University Of Georgia Research Foundation, Inc. Lysine-specific Porphyromonas gingivalis proteinase
US6017532A (en) * 1993-09-10 2000-01-25 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
JPH0797395A (ja) 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
US5948636A (en) 1994-03-29 1999-09-07 Kyowa Hakko Kogyo Co., Ltd. DNA and host cells encoding a cell surface protein of porphyromonas gingivalis
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
JP2000507245A (ja) * 1996-03-22 2000-06-13 ユニバーシティー オブ ジョージア リサーチ ファウンデーション，インコーポレイテッド Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｉｎｇｉｖａｌｉｓペプチドを含む免疫原性組成物および方法
AUPN901296A0 (en) * 1996-03-29 1996-04-26 University Of Melbourne, The Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
US7341727B1 (en) * 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
AUPO652897A0 (en) * 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
AUPP083997A0 (en) * 1997-12-10 1998-01-08 Csl Limited Porphyromonas gingivalis nucleotides
ATE534742T1 (de) * 1997-12-10 2011-12-15 Csl Ltd Polypeptide und nukleinsäuren von phorphorymonas gingivalis
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
US6444799B1 (en) * 1997-12-31 2002-09-03 Csl Limited P. gingivalis polynucleotides and uses thereof
AUPP893999A0 (en) * 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
US7090973B1 (en) * 1999-04-09 2006-08-15 Oscient Pharmaceuticals Corporation Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
GB9913437D0 (en) 1999-06-09 1999-08-11 Medical Res Council Fusion proteins
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
AUPQ718200A0 (en) * 2000-04-28 2000-05-25 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
US6576226B1 (en) * 2000-11-17 2003-06-10 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US20030083287A1 (en) 2000-11-30 2003-05-01 Burgess Nicola A. ginS
GB2381449A (en) 2001-10-31 2003-05-07 Smithkline Beecham Plc Oral hygiene compositions comprising an electron acceptor
JP2003192616A (ja) 2001-12-27 2003-07-09 Univ Nihon 歯周病用ｄｎａワクチン
JP2003286191A (ja) 2002-03-27 2003-10-07 Univ Nihon 歯周病用粘膜免疫ワクチン
JPWO2004083425A1 (ja) 2003-03-17 2006-06-22 麒麟麦酒株式会社 歯周病治療剤
AU2004266213A1 (en) * 2003-08-15 2005-03-03 University Of Florida Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
WO2005076010A2 (en) * 2004-02-06 2005-08-18 Council Of Scientific And Industrial Research Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
EP1799705A4 (en) * 2004-09-23 2008-11-05 Univ Melbourne Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
WO2008016385A2 (en) * 2006-01-20 2008-02-07 The University Of Washington Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof
US20100092471A1 (en) * 2006-06-27 2010-04-15 Oral Health Australia Pty Ltd Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease
WO2008124646A2 (en) 2007-04-06 2008-10-16 The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services Use of amyloid proteins as vaccine scaffolds
ES2714008T3 (es) * 2007-07-12 2019-05-24 Oral Health Australia Pty Ltd Tratamiento de biopelícula
US20110104179A1 (en) * 2009-06-19 2011-05-05 Oral Health Australia Pty Ltd Protease inhibitory peptides

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105418758A (zh) * 2015-12-03 2016-03-23 沈阳惠民生物技术有限公司 一种抗牙周病抗体的制备方法及其应用
CN113005069A (zh) * 2021-01-28 2021-06-22 广东海洋大学 一种减毒鰤鱼诺卡氏菌及其制备方法和应用
CN113005069B (zh) * 2021-01-28 2023-09-26 广东海洋大学 一种减毒鰤鱼诺卡氏菌及其制备方法和应用

Also Published As

Publication number Publication date
JP2014058541A (ja) 2014-04-03
US20130202641A1 (en) 2013-08-08
KR20100071964A (ko) 2010-06-29
EP2176413A4 (en) 2012-08-01
NZ595378A (en) 2013-04-26
SG182988A1 (en) 2012-08-30
WO2009006700A1 (en) 2009-01-15
CN102652831A (zh) 2012-09-05
JP2010532766A (ja) 2010-10-14
AU2008274907B2 (en) 2014-11-13
US20100297179A1 (en) 2010-11-25
EP2176413A1 (en) 2010-04-21
NZ582438A (en) 2012-03-30
CA2693717A1 (en) 2009-01-15
EP2604692A1 (en) 2013-06-19
NZ605037A (en) 2014-05-30
US8911745B2 (en) 2014-12-16
AU2008274907A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
US8911745B2 (en) Immunology treatment for biofilms
CN101842097B (zh) 用于生物膜治疗的药物组合物
US8916166B2 (en) Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
AU2013203250B2 (en) Immunology treatment for biofilms
HK1185102A (en) Immunology treatment for biofilms
HK1189800A (en) Biofilm treatment
HK1143530B (en) Biofilm treatment

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100922